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Abstract
Background: A Royal Statistical Society Working Party recently recommended that “Greater use should be made of
numerical, as opposed to verbal, descriptions of risk” in first-in-man clinical trials. This echoed the view of many
clinicians and psychologists about risk communication. As the clinical trial industry expands rapidly across the
globe, it is important to understand risk communication in Asian countries.
Methods: We conducted a cognitive experiment about participation in a hypothetical clinical trial of a pain relief
medication and a survey in cancer and arthritis patients in Singapore. In part 1 of the experiment, the patients
received information about the risk of side effects in one of three formats (frequency, percentage and verbal
descriptor) and in one of two sequences (from least to most severe and from most to least severe), and were
asked about their willingness to participate. In part 2, the patients received information about the risk in all three
formats, in the same sequence, and were again asked about their willingness to participate. A survey of preference
for risk presentation methods and usage of verbal descriptors immediately followed.
Results: Willingness to participate and the likelihood of changing one’s decision were not affected by the risk
presentation methods. Most patients indicated a preference for the frequency format, but patients with primary
school or no formal education were indifferent. While the patients used the verbal descriptors “very common”,
“common” and “very rare” in ways similar to the European Commission’s Guidelines, their usage of the descriptors
“uncommon” and “rare” was substantially different from the EU’s.
Conclusion: In this sample of Asian cancer and arthritis patients, risk presentation format had no impact on
willingness to participate in a clinical trial. However, there is a clear preference for the frequency format. The lay
use of verbal descriptors was substantially different from the EU’s.
Background
Many studies on informed consent for clinical trials
have demonstrated that people often have limited
understanding about the trials they agreed to participate
in [1]. An important consideration in accepting a medi-
cal product or participating in a trial is the risk of harm
[2]. In 2006, a phase I trial at the Northwick Park Hos-
pital, London, resulted in six volunteers suffering from
life-threatening cytokine release syndrome [3]. In
response to the Northwick Park Hospital incident, the
Royal Statistical Society (RSS) commissioned a Working
Party to investigate how to improve the conduct of
first-in-man medical research. The RSS Working Party
recommended [3], among other things, that “Greater
use should be made of numerical, as opposed to verbal,
descriptions of risk”. This is not a new suggestion. In
2003, the Journal of the Royal Statistical Society, Series
A [4], and the British Medical Journal [5] each published
a special issue on risk communication, in which various
statisticians and clinicians make similar suggestions.
Some psychologists who specialised in decision making
have also recommended the use of numbers, not words,
for description of risk [6].
However, there are limited data and inconclusive
evidence on whether risk presentation formats actually
influence understanding and decision making in real or
hypothetical clinical situations [7-13], although the
evidence is strong that the use of frequency presentation
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Studies that focused on comparison of relative versus
absolute risk reduction or comparison of different gra-
phical tools are important, but they are not directly rele-
vant to the present theme and therefore not discussed
here. A recently published systematic review focused on
communicating cardiovascular risk information [12]. It
concluded that “numerical presentation of risk as
opposed to simple risk categories (e.g. high, moderate,
low) appears to lead to more accurate risk perceptions”,
but “there is conflicting evidence regarding whether [dif-
ferent] numerical presentation formats may affect per-
ceptions or emotions” [12]. Similarly, after a review of
empirical findings and consultations with experts in risk
communication, Lipkus [8] concluded that “few overall
recommendations could be suggested” for the use of
numeric, verbal and visual formats. A study of screening
for Down’s syndrome in pregnant women showed that
94 out of 97 (97%) and 102 out of 112 (91%) women
who received test results in numerical probability and
verbal description, respectively, correctly understood
their test results, and that a normal approximation test
gave a 1-sided p-value 0.04 for this difference in propor-
t i o n s[ 1 5 ] .H o w e v e r ,aF i s h e r ’s exact test would give
p-values 0.071 (1-sided) or 0.093 (2-sided) for this data.
A recent online study of adult volunteers recruited from
the general public found that the use of frequency pre-
sentation did not make a difference in decision to take a
cholesterol lowering drug in a hypothetical scenario, but
it was associated with higher satisfaction with informa-
tion [16]. A small-scale study (n = 84) in Singapore on
willingness to receive an influenza vaccine among
healthcare workers and students showed only a small
difference between those who received risk information
in frequency versus percentage format [2]. All but one
(Singapore) of the aforementioned or cited empirical
studies were conducted in either Europe or North
America; all but one (New Zealand) of the studies
included in the systematic review of Waldron et al. [12]
were conducted in either Europe or North America.
There is a paucity of information about the impact of
risk presentation formats in Asian culture.
As u r v e yo fp a t i e n t sw h oa t t e n d e dau n i v e r s i t yh o s p i -
tal in Japan found that more patients preferred the use
of words only (41.4%) than numbers only (35.8%) in the
communication of risk [17]. This is in sharp contrast
with studies conducted in North America and Europe,
which tended to suggest that respondents preferred to
receive medical [18-21] and general probability informa-
tion in numerical formats [22]. This highlights the
importance of conducting research in a local setting.
The Japanese survey [17] and a series of British survey
[23,24] showed that there was a wide variation in the
understanding and usage of verbal descriptors of drug
side effects.
Another aspect of information presentation concerns
t h es e q u e n c eo fp r e s e n t i n gs i d ee f f e c t s ,e . g .f r o mm o s t
to least severe or the other way round. The impact of
this on patient decision remains largely unexplored [18].
It has been suggested that effectiveness of communica-
tion tends to increase when the communication is
designed to respond to consumers’ preferences [18,25].
It remains uncertain what the public in Asian countries
prefer regarding risk presentation in medical care and
clinical trials, and thus it is not clear how best to pre-
sent information to potential clinical trial participants.
The expansion of the clinical trial industry around the
globe, and especially in Asia, has been rapid in the last
decade. There is not conclu s i v ee v i d e n c ea b o u tt h e
impact of risk presentation formats and people’sp r e f e r -
ence, especially in non-Caucasian populations. We
therefore conducted an empirical study to examine risk
communication and decision making in the context of
clinical trial practice in Singapore. The study included a
cognitive experiment and a post-experiment survey on
preferences about risk communication. Three formats of
risk presentation were considered, namely, frequency
(e.g. 1 in 200), percentage (e.g. 0.5%) and verbal descrip-
tion (e.g. uncommon). The verbal description followed
the European Union’s guideline on drug labeling [26].
In this guideline, risk levels of ≤ 0.01%, > 0.01% to 0.1%,
> 0.1% to 1%, > 1% to 10%, and > 10% were described
as “very rare”, “rare”, “uncommon”, “common” and “very
common”, respectively. The guideline was not based on
patient inputs on the descriptors. It is not clear whether
patients would interpret these risk levels as the EU
intended [2,23]. The secondary purposes included com-
paring the impact of presenting information on risk of
side effects in two different sequences, i.e. from most to
least and from least to most severe, eliciting patient pre-
ference on risk communication, and exploring whether
patients’ usage of verbal descriptors of risk agrees with
that of the EU.
Methods
Study design
Patients were recruited from an arthritis clinic of the
Singapore General Hospital and the outpatient clinic of
the National Cancer Center, Singapore. The study was
approved by the Institutional Review Boards of the two
institutions. Patients were recruited from the clinics
while they were in the waiting area. A research assistant
w i t had e g r e ei np s y c h o l o g ye x p l a i n e dt h es t u d ya n d
obtained written informed consent. The first part of the
study was a cognitive experiment, which used a factorial
design to study the impact of the aforementioned three
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ness to participate and likelihood to change one’s will-
ingness after given additional information. Consented
consecutive participants were presented with informa-
tion in one of the 6 combinations in a pre-specified
order, i.e. sequential allocation instead of true randomi-
sation. A hypothetical situation about a clinical trial of a
pain therapy was presented to each participant. It was
made clear to the study participants that they were par-
ticipating in a cognitive experiment and preference sur-
vey about risk communication and willingness to take
part in a hypothetical clinical trial. The research assis-
tant also stated that there were no right or wrong
answers and that we were only interested in what the
participant thought. Participants were given a Card 1
that showed information about side effects of a new
medication for pain relief in one of the 6 ways of risk
presentation, and then asked whether they would be
willing to take part in this clinical trial. An example of
card 1 presenting information in the frequency format
and the least to most severe sequence is in Additional
file 1. They were then presented with Card 2, with the
same risk information presented in all three formats
being studied (but in the same sequence in severity),
and were asked for their decision again. The Card 2 that
complements the Card 1 in Additional file 1 is also
included in the Additional file. A change in decision
would indicate a potential problem in the format the
participants were given initially.
The cognitive experiment was followed by a short sur-
vey to assess the participants’ preference for risk com-
munication. The research assistant recapitulated that in
the experiment just completed we had presented risk
information in three different formats, and then asked
the participant which of these formats s/he preferred
most. In order to avoid the potential of an order effect
[27,28], the sequence of the three formats (total six
sequences) in the recapitulation were balanced across
consecutive participants. To avoid unnecessary complex-
ity, the six sequences in the preference section were
linked to the six combinations of risk presentation in
Card 1. For example, if Card 1 presented risk in percen-
tage format from least to most severe side effects, the
research assistant recapitulated that the experiment just
completed had presented risk “in percentages (e.g.
0.2%), in descriptive terms (e.g. uncommon), and in fre-
quencies (e.g. 1 out of 500)"; if Card 1 presented risk in
percentage format from least to most severe side effects,
the recapitulation was “in percentage (e.g. 0.2%), in fre-
quencies (e.g. 1 out of 500) and descriptive terms (e.g.
uncommon)”. That is, the first format in the recapitula-
tion was the format used in Card 1, whereas the second
and third were determined by the severity sequence in
Card 1. Furthermore, the participants were asked which
one of the five EU descriptors ("very rare”,..., “very com-
mon”) best described the frequency of 1 out of 40, 1 out
of 4,000, 1 out of 5, 1 out of 200 and 1 out of 20,000.
The five questions were asked in this order. The reason
of using this order instead of using an order with mono-
tonic increase or decrease in risk presented was to avoid
one answer being easily affected by the previous answer.
These figures were chosen so that they covered each of
the EU’s descriptors from “very common” to “very rare”.
Statistical considerations
A previous cognitive experiment suggested that the per-
centages of people who change their treatment decision
after given initial and then supplementary information
range between 25% and 5% for different information
sets [29]. A sample size of 80 per risk presentation for-
mat would give 90% power and 5% type I error rate in
detecting this level of difference (based on a two-sample
test of proportion 0.25 vs 0.05). A total sample size of
80×3 = 240 participants is needed. To explore whether
there is a difference between participants with non-life-
threatening versus life-threatening diseases, about one-
third of the participants were recruited from the arthri-
tis clinic and two-thirds from the cancer center. The
number of arthritis and cancer patients offered about
90% power for detecting a 20% difference in willingness
to participate. Only English speaking participants were
recruited because the study involved the EU descriptors
of risk, which are in English. In 2000, 71% of the Singa-
porean population was literate in English (http://www.
singstat.gov.sg; accessed 28 Oct 2009), the lingua franca
of Singapore. Fisher’s exact test was used to compare
distribution of categorical variables across groups of par-
ticipants; McNemar test was used to compare change in
willingness to participate; Binomial probability test was
used to assess whether stated preferences were ran-
domly distributed. All tests were conducted in Stata ver-
sion 10.1 [30], using the “exact”, “symmetry” and “bitest”
functions.
Results
Participant characteristics
A total of 240 participants were recruited, of which 162
were cancer patients and 78 were arthritis patients. The
average age was 52 years (SD = 13 and range from 21 to
87) and 58% were female (Table 1). Fifty-six participants
had university degree or higher education level; 154 had
secondary school or polytechnic diploma level. The dis-
tribution of the background characteristics was very simi-
lar across the three presentation formats (Table 1). The
distribution was also very similar across the two
sequences of presentation according to severity and
across all six groups defined by the three formats and
two sequences (details not shown in table).
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The number of participants who received Card 1 in fre-
quency, percentage and verbal description formats were
82, 80 and 78, respectively (Table 2). After reading Card
1, 29, 26 and 28 participants in the frequency, percen-
tage and verbal description group, respectively, indicated
a willingness to participate in the trial. There was no
significant difference between the three formats (P =
0.886). After reading Card 2, the proportion of partici-
pants indicating a willingness to participate changed to
51%, 44% and 46% in the frequency, percentage and ver-
bal description groups, respectively. The increase within
each group was statistically significant (each P < 0.05).
There was no significant difference across the three
groups in proportion of participants changing their
mind (P = 0.529). There was no statistically significant
pair-wise difference between the three groups in willing-
ness to participate after Card1 and Card 2 or in the like-
lihood of changing decision (each P > 0.05). Among
those who changed their mind, most changed from
unwilling to willing to take part in the clinical trial. Test
of equal proportion in each of these outcomes in arthri-
tis versus cancer patients showed no significant differ-
ence (each P > 0.05; details not shown in table).
Exploratory analyses repeating the above tabulations in
participants with different levels of educational back-
ground showed similar results (details not shown in
table).
Table 3 shows the willingness to participate after Card
1 and Card 2, and the proportion of participants who
changed their mind after Card 2 for the two groups
with side effects presented from increasing and decreas-
ing severity. There results were similar across the two
groups.
Preference
When asked what their most preferred way of risk pre-
sentation format was (among the three used in the
experiment), 43% indicated that they most preferred the
frequency format, showing statistical significance against
Table 1 Patient characteristics (N = 240)
Variable Category/statistics All participants Frequency group Percentage group Descriptors group P*
Age (years) Mean (SD) 51.5 (12.6) 52.3 (11.1) 51.6 (13.2) 50.6 (13.6) 0.694
Gender Female 140 (58.3%) 35 (42.7%) 32 (40.0%) 33 (42.3%) 0.945
Male 100 (41.7%) 47 (57.3%) 48 (60.0%) 45 (57.7%)
Education Primary or below 29 (12.1%) 12 (14.6%) 10 (12.5%) 7 (9.1%) 0.673
Secondary or Diploma 154 (64.2%) 53 (64.6%) 48 (60.0%) 53 (68.8%)
Graduate or Postgraduate 56 (23.3%) 17 (20.7%) 22 (27.5%) 17 (22.1%)
Marital status Married 51 (21.3%) 18 (22.0%) 16 (20.0%) 17 (21.8%) 0.947
Single 183 (76.3%) 61 (74.4%) 62 (77.5%) 60 (76.9%)
Divorce/Separated 6 (2.5%) 3 (3.7%) 2 (2.5%) 1 (1.3%)
Ethnicity Chinese 188 (78.3%) 64 (78.1%) 66 (82.5%) 58 (74.4%) 0.901
Malay 21 (8.8%) 8 (9.8%) 5 (6.3%) 8 (10.3%)
Indian 16 (6.7%) 6 (7.3%) 4 (5.0%) 6 (7.7%)
Others 15 (6.3%) 4 (4.9%) 5 (6.3%) 6 (7.7%)
Disease type Arthritis 78 (32.5%) 28 (34.2%) 26 (32.5%) 24 (30.8%) 0.831
Breast cancer 49 (20.4%) 17 (20.7%) 16 (20.0%) 16 (20.5%)
Colorectal cancer 25 (10.4%) 9 (11.0%) 7 (8.8%) 9 (11.5%)
Gynaecological cancer 13 (5.4%) 4 (4.9%) 7 (8.8%) 2 (2.6%)
Head and neck cancer 17 (7.1%) 5 (6.1%) 6 (7.5%) 6 (7.7%)
Lung cancer 18 (7.5%) 9 (11.0%) 5 (6.3%) 4 (5.1%)
Other cancers 40(16.7%) 10 (12.2%) 13 (16.3%) 17 (21.8%)
* Test of difference between three formats: ANOVA for age; Fisher’s exact test for categorical variables.
Table 2 Willingness to participate, change of mind and whether format affects decision by risk presentation format
Response Frequency
(n = 82)
Percentage
(n = 80)
Description
(n = 78)
P-value
Willingness to participate after card1 29 (35.4%) 26 (32.5%) 28 (35.9%) 0.886
Willingness to participate after card2 42 (51.2%) 35 (43.8%) 36 (46.2%) 0.636
Change of mind 15 (18.3%) 11 (13.8%) 6 (20.5%) 0.529
Yes to No 1 1 4
No to Yes 14 10 12
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two percent and 25% of the participants preferred the
percentage and verbal description format respectively.
Figure 1 shows the distribution of preferred formats by
risk presentation formats in Card 1. Interestingly, within
each group, participants tended to indicate a preference
for a risk presentation format they did not initially
received in Card 1. Figure 2 shows participant prefer-
ence by education level. The higher the education level
was, the stronger the preference for frequency format.
Among participants with primary or below education
background, the three formats were roughly equally pre-
ferred (P = 0.678).
Verbal descriptions
Figure 3 shows the EU descriptors that the participants
assigned to the frequencies from 1 out of 5 to 1 out of
20,000. The x-axis shows the frequencies the partici-
pants were asked to describe using the EU descriptors.
The five bars for each frequency show the percentage
distribution of the five EU descriptors being chosen to
describe the frequency shown on the x-axis. According
to the EU guidelines, these frequencies of side effects
should be described as “very rare”, “rare”, “uncommon”,
“common” and “very common”, respectively. Agreement
on the two most frequent (1/5 and 1/40) and the least
frequent (1/20,000) were fairly strong, with almost half
(56%, 49% and 42%, respectively) of the participants
assigning the descriptors “very common”, “common”,
and “very rare” to them. However, for the frequencies of
1 out of 200 and 1 out of 4,000, the agreement between
the participants and the EU intended use of the descrip-
tors were more limited. Only 29% of the participants
rated 1 out of 200 as “uncommon” and 24% rated 1 out
of 4,000 as “rare” (as EU intends). The modes were one
grade above the EU guideline suggested: 45% of the par-
ticipants considered 1 out of 200 common (which is
“uncommon” as per EU) and 34% consider 1 out of
4,000 uncommon (which is “rare” as per EU)
Discussion
The last decade has seen a significant rise in concerns
about how risk is communicated [3-6]. These concerns
involve the communication of risk to the general public,
patients, users and potential users of screening or
genetic tests. As medical research expands globally, con-
cerns about understanding of trial information in studies
conducted outside Western societies is also rising [31].
Table 3 Willingness to participate, change of mind and whether format affects decision by order of risk presentation
Response Increasing severity
(n = 120)
Decreasing severity
(n = 120)
P-value
Willingness to participate after card1 44 (36.7%) 39 (32.5%) 0.587
Willingness to participate after card2 58 (48.3%) 55 (45.8%) 0.796
Change of mind 18 (15.0%) 24 (20.0%) 0.396
Yes to No 2 4
No to Yes 16 20
Figure 1 Preference for risk presentation format, by actual risk presentation format in Card 1.
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chologists and statisticians for the use of numerical
information in risk communication [4-6]. The RSS
Working Party also suggested the use of numerical for-
mat for presenting medical risk in the recruitment of
clinical trial participants [3]. However, there was no
conclusive evidence as to whether doing this does have
an influence on patients’ understanding, decision mak-
ing, and behaviour [7-13]. We thus conducted a cogni-
tive experiment using a hypothetical clinical trial to
shed light on this issue. We have studied willingness to
participate, which had been shown to be predictive of
actual participation in longitudinal studies [32-34].
Improving trial participation is of course but just one
facet in the process of conducting a good clinical trial
and there are other aspects which are just as important.
We have also examined concordance in willingness
to participate before and after more comprehensive pre-
sentation, which relate to understanding [29,35].
Furthermore, we explored patients’ preference in risk
presentation formats, usage of descriptive terms, and
whether sequence of presenting more or less severe side
effects would affect decisions.
We used a scenario of a pain relieving medication
because pain is a near universal experience and there-
fore most participants could relate to this. The limita-
tion of the study includes that willingness and decision
to participate in clinical trials probably is influenced by
the purpose and nature of treatment. So the present
finding should not be over generalized to all other
Figure 2 Preference for risk presentation format, by educational background.
Figure 3 Patients’ verbal description of risk levels given in the frequency format.
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allocation of Card 1 was sequential rather than rando-
mised. In practice, we see no way how in this context
recruitment could become selective according to the
risk format in the next Card 1. Furthermore, the distri-
bution of participant characteristics was very similar
across groups (Table 1), strongly suggesting that the
allocation was practically random. A third limitation is
that we only used a limited number of endpoints to
assess the impact of risk presentation formats. There are
other potential endpoints such as satisfaction with infor-
mation. But inclusion of more endpoints might compro-
mise quality and execution of the study (e.g. by having
too lengthy interview that might affect patients’ atten-
tion/response) and we decided not to.
Our study found that patients who received risk infor-
mation in the three formats (frequency, percentage and
verbal description) and two sequences (least to most
a n dm o s tt ol e a s ts e v e r e )s h o w e dn od i f f e r e n c ei nw i l l -
ingness to participate in the trial. Furthermore, there
was no difference in the likelihood of changing their
mind after being given information in additional formats
either. Our data suggests that the way of presenting
information makes limited practical difference in will-
ingness to participate in trials. The participants in all
three groups had a tendency to change from unwilling
to willing to participate after presented with Card 2. It
might be that information presented in additional for-
mats helped to reduce uncertainty or the feeling of
being uncertain, which in turn contributed to re-evalua-
tion of situation or decision making. However, the find-
ing only applies to the present risk scenario. In other
risk scenarios, there is no guarantee that additional pre-
sentation of information will lead to the same direction
of change.
Nevertheless, the participants showed a clear prefer-
ence for risk to be presented in the frequency format.
This reinforces the recommendations from the clinical,
psychology and statistics circles. Moreover, description
in words had the smallest number of participants who
preferred it. The finding is in contrast to that of the
Japanese study [17]. It appears that there is substantial
cultural diversity in this regard within the region.
A potential participant’s willingness to participate in a
trial is not purely determined by the risk of unwanted
effects. There are other benefits and barriers involved in
the decision making process. The apparent discrepancy
between participants’ preference for risk to be presented
in the frequency format and the lack of effect on their
willingness to participate in a trial suggests that, even
though participants have their preference, there are mul-
tiple factors that affect willingness and decision to parti-
cipate in clinical trials. Ways of presenting the risk of
side effects do not dominate this decision making
process.
To respect patients’ preference, and based on the
assumption that communication is more effective when
it corresponds to consumers’ preferences [18,25], one
may consider the use of frequency format in presenting
side effects in patient information sheets during clinical
trial recruitment, if the clinical trial must chose to use
one and only one format. However, our study shows
that patients who received one format of risk informa-
tion tended to indicate preference for some other for-
mat. They seemed not satisfied with only one way of
communication. As such, we would recommend the use
of multiple presentation formats to facilitate decision
making, an example can be seen from our Card 2 in the
Additional file.
The use of description of risk in words has been a
debatable practice, as the understanding of vocabulary
may vary from one culture to another and from one
person to another. One way of presenting risk by words
is to follow the EU’s guideline on drug labeling. Our
data suggest that the patients used these descriptors in
ways somewhat different from the EU, although the
agreement between the patients and the EU guideline
for the more extreme frequencies was reasonably good
in our opinion. Most of the patients describe the mid-
range frequencies 1 out of 200 and 1 out of 4,000 as
common and uncommon, respectively, while the EU
descriptor for these were “uncommon” and “rare”,
respectively. The use of the EU descriptors only may
give an impression of the side effects being less frequent
than the patients think. Hence, the use of verbal
descriptors only is not recommended.
The preference for risk of side effect being communi-
cated in frequency format was clearly associated with
higher level of educational background. Among those
with primary school or no formal education background,
there was practically no preference between the three
choices: The distribution was consistent with random
distribution (i.e. one-third for each of the three choices).
In a traditional clinician-patient relationship, clinicians
play a paternalistic role and patients play a trusting role
[6]. It might be that these patients were more inclined
to follow this tradition and therefore did not indicate a
clear preference. It should be emphasized that this is
neither a positive nor negative characteristic. However,
it is imperative that clinicians and clinical trialists make
every effort to effectively communicate with all patients
and actively promote their understanding of the poten-
tial risk of treatments or trial participation. As second-
ary and tertiary education become more common, and
in societies with higher educational coverage, the desire
for the frequency format is likely to be stronger.
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In this sample of Asian cancer and arthritis patients, risk
presentation format had no impact on willingness or
change in willingness to participate in trials. However,
there is a clear preference for the frequency format
among patients with secondary or post-secondary edu-
cation. The lay use of verbal descriptors was substan-
tially different from the EU’s.
Additional material
Additional file 1: Appendix 1. Example of Card 1 using frequency
format in the least to most severe sequence and the complementing
Card 2 that uses all three formats in the same sequence.
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